Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Open-label Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT03815903 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.

NCT NCT03815903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Open-label Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Lead sponsor
Barretos Cancer Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
December 19, 2018
Completion date
December 31, 2025
Enrollment
434 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced malignant neoplasm